A Phase I Study of Ovarian Cancer Peptides Plus GM-CSF and Adjuvant With Ovarian, Tubal or Peritoneal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00437502
Recruitment Status : Completed
First Posted : February 21, 2007
Last Update Posted : November 19, 2012
Information provided by (Responsible Party):
Michael Morse, MD, Duke University